Drug intelligence / Profile preview

tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate

Development stage
Unknown
Modality
Small Molecules
01

Overview

tert-butyl [(2-amino‐4‐oxo‐4,7‐dihydro‐3H‐pyrrolo[2,3‐d]pyrimidin‐5‐yl)methyl]carbamate is a synthetic small molecule belonging to the pyrrolopyrimidine class. It is an experimental compound with no approved medical indications or known clinical development as of June 2025. The compound has been referenced in chemical and drug databases but lacks detailed information on its mechanism of action or therapeutic use. Its structure suggests it may be a derivative or intermediate related to nucleoside analogs or antifolate agents; however specific pharmacological activity has not been established in public sources[1][2][8].

Other names
tert-butyl ((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-5-yl)methyl)carbamatetert-butyl N-( (2-amino–4–oxo–3H, 4H, 7H-pyrrolo[2,3-d]pyrimidin–5–yl )methyl )carbamateTert-butyl n-( {2-amino–4–oxo–3h, 4h, 7h-pyrrolo[2,3-d]pyrimidin–5–yl}methyl )carbamate2-Methyl‑2-propanyl [(2-amino‑4‑oxo‑4,7‑dihydro‑3H‑pyrrolo[2,3-d]pyrimidin‑5‑yl)methyl]carbamate

Beyond the preview

Go deeper on tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call